CA Hurwitz

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Evolution of the Cancer Stem Cell Model

The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia

Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.

Infections During Induction Therapy of Protocol CCLG-2008 in Childhood Acute Lymphoblastic Leukemia

Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

Cytogenetics in acute leukemia

De novo protein design. I. in search of stability and specificity

Prognostic Impact of Acute Myeloid Leukemia Classification: Importance of Detection of Recurring Cytogenetic Abnormalities and Multilineage Dysplasia on Survival

Modulation of oxidative stress as an anticancer strategy

Survivors of childhood and adolescent cancer: life-long risks and responsibilities

3D-printing techniques in a medical setting: a systematic literature review

Chronic Health Conditions in Adult Survivors of Childhood Cancer

Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors

CD45 Gating for Routine Flow Cytometric Analysis of Human Bone Marrow Specimens

The Emerging Hallmarks of Cancer Metabolism

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

The anti-angiogenic basis of metronomic chemotherapy

Realistic Pathologic Classification of Acute Myeloid Leukemias

Childhood acute lymphoblastic leukemia

L‐asparaginase treatment in acute lymphoblastic leukemia

Flow cytometric analysis of cell‐surface and intracelluar antigens in leukemia diagnosis

Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t(8; 21)(q22; q22)

Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Mechanisms of Cancer Drug Resistance

Nomenclature of monocytes and dendritic cells in blood

Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA

Molecular Genetics of Acute Lymphoblastic Leukemia

Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia

Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry

Immunotoxins for targeted cancer therapy

Developments in Purging in Autotransplantation

The World Health Organization (WHO) classification of the myeloid neoplasms

Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)

Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children [see comments]

Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors.

Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children [see comments]

Asynchronous antigen expression in B lineage acute lymphoblastic leukemia

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.